ÇѾç´ë±¸¸®º´¿ø, ÇãÁØ¿µ±³¼ö ´ëÇÑÇ÷¾×ÇÐȸ ¿ì¼ö³í¹®»ó ¼ö»ó

´º½ºÀÏÀÚ: 2022³â05¿ù03ÀÏ 10½Ã19ºÐ

[º¸°ÇŸÀÓÁî] ÇѾç´ëÇб³±¸¸®º´¿ø Ç÷¾×Á¾¾ç³»°ú ÇãÁØ¿µ ±³¼ö(»çÁø)°¡ 2022³â 4¿ù2ÀÏ ¿­¸° 2022³âµµ ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2022)¿¡¼­ Blood Research ¿ì¼ö³í¹®»óÀ» ¼ö»óÇÏ¿´´Ù.
 
´ëÇÑÇ÷¾×ÇÐȸ¸¦ ´ëÇ¥ÇÏ´Â ±¹Á¦ÇмúÁöÀÎ Blood Research´Â ¿ì¼öÇÑ ³»¿ë°ú ÀÇÇйßÀü¿¡ ±â¿©ÇÑ ¹Ù°¡ Å« ³í¹®À» ¼±Á¤ÇÏ¿©Blood Research ¿ì¼ö³í¹®»óÀ» ¼ö¿©ÇÏ°í ÀÖ´Ù.
ÇãÁØ¿µ ±³¼ö´Â Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis ¶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î À§ »óÀ» ¼ö»óÇß´Ù. 
 
ÇãÁØ¿µ ±³¼ö´Â ÇѾç´ëÇб³ÀǴ븦 Á¹¾÷ÇÏ°í °æÈñ´ëÇб³ ´ëÇпø¿¡¼­ ¼®»çÇÐÀ§, ¼º±Õ°ü´ë ´ëÇпø¿¡¼­ ¹Ú»çÇÐÀ§¸¦ ÃëµæÇßÀ¸¸ç, ´ëÇѳ»°úÇÐȸ, ´ëÇÑÇ÷¾×ÇÐȸ, ´ëÇÑÁ¾¾ç³»°úÇÐȸ, ´ëÇÑÇ׾Ͽä¹ý¿¬±¸È¸, ¹Ì±¹¾Ï¿¬±¸Çùȸ (American Association for Cancer Research, AACR), ¹Ì±¹Ç÷¾×ÇÐȸ (American Society of Hematology, ASH) µî¿¡¼­ È°¹ßÇÑ È°µ¿À» ÇÏ°í ÀÖ´Ù.
 
 
 

ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼­ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.